References

  1. Ghorbani A, Ehsanpour A, Roshanzamir N, Omidvar B. Alterations in antibiotic susceptibility of urinary tract infection pathogens. J Nephropathol. 2012 Apr;1(1):43-8. PubMed | Google Scholar

  2. Ronald AR, Nicolle LE, Stamm E et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents. 2001 Apr;17(4):343-8. PubMed | Google Scholar

  3. Barisić Z, Babić-Erceg A, Borzić E, Zoranić V, Kaliterna V, Carev M. Urinary tract infections in South Croatia: etiology and antimicrobial resistance. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:61-4. PubMed | Google Scholar

  4. Jinnah F, Islam MS, Rumi MAK, Morshed MG, Huq F. Drug sensitivity pattern of E. Coli causing urinary tract infection in diabetic and non-diabetic patients J Int Med Res. 1996 May-Jun;24(3):296-301. PubMed | Google Scholar

  5. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002 Jul 8;113 Suppl 1A:14S-19S. PubMed | Google Scholar

  6. Lau SM, Peng MY, Chang FY. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect. 2004 Jun; 37(3):185-91. PubMed | Google Scholar

  7. Cuba GT, Pignatari AC, Patekosky KS, Luchesi LJ, Kiffer CR. Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract. Braz J Infect Dis. 2014 Sept-Oct;18(5):512-7. PubMed | Google Scholar

  8. Irenge LM, Kabego L, Vandenberg O, Chirimwami RB, Gala JL. Antimicrobial resistance in urinary isolates from inpatients and outpatients at a tertiary care hospital in South-Kivu Province (Democratic Republic of Congo). BMC Res Notes. 2014 Jun 18;7:374. PubMed | Google Scholar

  9. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University Specialized Hospital, Southwest Ethiopia. Ethiop J Health Sci. 2011 Jul;21(2):141-6. PubMed | Google Scholar

  10. Villar HE, Jugo MB, Macan A, Visser M, Hidalgo M, Maccallini GC. Frequency and antibiotic susceptibility patterns of urinary pathogens in male outpatients in Argentina. J Infect Dev Ctries. 2014 Jun 11;8(6):699-704. PubMed | Google Scholar

  11. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community–acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001 Jul 1;33(1):89-94. Epub 2001 Jun 5. PubMed | Google Scholar

  12. Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis. 2009 Mar;13(2):140-4. Epub 2008 Aug 13. PubMed | Google Scholar

  13. Tessema B, Kassu A, Mulu A, Yismaw G. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia. Ethiop Med J. 2007 Jan;45(1):61-7. PubMed | Google Scholar

  14. Raka L, Mulliqi-Osmani G, Berisha L, Begolli L, Omeragiq S, Parsons L, Salfinger M, Jaka A, Kurti A, Jakupi X. Etiology and susceptibility of urinary tract isolates in Kosova. Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S2-5. PubMed | Google Scholar

  15. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?. Mem Inst Oswaldo Cruz. 2006 Nov;101(7):741-8. PubMed | Google Scholar

  16. Sefton AM. The impact of resistance on the management of urinary tract infections. Int J Antimicrob Agents. 2000 Dec;16(4):489-91. PubMed | Google Scholar

  17. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999 Oct;29(4):745-58. PubMed | Google Scholar

  18. McCraig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States 1992-2000. Emerg Infect Dis. 2003 Apr;9(4):432-37. PubMed | Google Scholar

  19. Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 1997 Jun;5(6):234-40. PubMed | Google Scholar

  20. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999 Apr;43(4):727-37. PubMed | Google Scholar

  21. Miller GH, Sabatelli FJ, Hare RS, Glupczynski Y, Mackey P, Shlaes D, Shimizu K, Shaw KJ, the aminoglycoside resistance study groups. The most frequent aminoglycoside resistance mechanisms changes with time and geographic area: a reflection of aminoglycoside usage patterns? Clin Infect Dis. 1997 Jan;24(1):S46-S62. PubMed | Google Scholar

  22. Javier Terán F, Alvarez M, Suárez JE, Mendoza MC. Characterization of two aminoglycoside-(3)-N-acetyltransferase genes and assay as epidemiological probes. J Antimicrob Chemother. 1991 Sep;28(3):333-46. PubMed | Google Scholar

  23. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003 May;51(5):1109-17. PubMed | Google Scholar

  24. Bălăşoiu M, Bălăşoiu AT, Mănescu R, Avramescu C, Ionete O. Pseudomonas aeruginosa resistance phenotypes and phenotypic highlighting methods. Curr Health Sci J. 2014 Apr-Jun;40(2):85-92. Epub 2014 Mar 29. PubMed | Google Scholar